Task order award entitled, "quick turnaround testing of communication effectiveness"

Ended Awarded Last action

Contract number
75F40118F18003
Awardee
Awarding agency
Obligated
$260,330

Award facts

Contract value 100% obligated
$260,330.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541820 Public Relations Agencies
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00004 · To extend the period of performance from 12/30/2022 to 9/11/2023. $0
Other Administrative Action P00003 · The purpose of this modification is to incorporate hhsar 352.232-71, electronic submission of payment requests (FEB 2022) and FDA electronic invoicing and… $0
Other Administrative Action P00002 · Key personnel change $0
Other Administrative Action P00001 $0
Original award $260,330

About this award

The U.S. Food and Drug Administration (FDA) awarded a task order to Westat, Inc. for Quick Turnaround Testing of Communication Effectiveness under the Quick Turnaround Social Science Research Services program. This $260,330 firm fixed-price contract call, issued on September 12, 2018, extended the period of performance through September 11, 2023, with work performed in Potomac, Maryland. The award was not designated with a set-aside and was issued through the Advertising & Integrated Marketing Solutions (AIMS) GSA Schedule. Westat, a prominent professional services firm headquartered in Rockville, Maryland, brings substantial expertise in social science research, survey development, data collection, and program evaluation to this engagement.

As a leading federal contractor with extensive experience supporting health agencies including the FDA, CDC, and NIH, Westat is well-positioned to deliver rapid-turnaround research services focused on assessing communication effectiveness. This task order represents typical FDA work in evaluating and refining public health messaging and stakeholder communication strategies. The contract reflects Westat's established role as a prime contractor for complex research initiatives, with no small business set-aside designation, indicating the agency's reliance on the contractor's sophisticated capabilities and infrastructure to meet its communication research objectives.

Quick answers

Who was awarded contract 75F40118F18003?

75F40118F18003 was awarded to Westat, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 12, 2018.

How much is contract 75F40118F18003 worth?

The government has obligated $260,330 on 75F40118F18003.

Is contract 75F40118F18003 an order under another contract?

Yes. 75F40118F18003 is a BPA call under GS23F0155K-HHSF223201510001B, a blanket purchase agreement, on Advertising & Integrated Marketing Solutions (AIMS).

Was contract 75F40118F18003 competed?

The extent of competition for 75F40118F18003 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award